Last update Jan. 30, 2021


Very Low Risk

Safe. Compatible. Minimal risk for breastfeeding and infant.

Short-acting beta-adrenergic bronchodilator, similar in characteristics to Terbutaline.
Indicated in the treatment of asthma.
Administration preferably inhaled (also oral or intravenous).

Its large volume of distribution and poor absorption after inhaled administration make it highly unlikely that significant quantities will pass into milk.
Its low oral bioavailability would make it difficult its passage to the infant’s plasma through breast milk.

Inhaled preparations are preferred since they are absorbed less than 10 %.

Several medical societies, experts authors and expert consensus consider the use of inhaled bronchodilators to be safe during breastfeeding (Hale, Lactmed, Amir 2011, National Asthma 2004, Nelson 2001, Ellsworth 1994).
List of WHO essential medicines: compatible with breastfeeding (WHO / UNICEF 2002).


Suggestions made at e-lactancia are done by APILAM team, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

Albuterol is also known as

Albuterol in other languages or writings:


Variable Value Unit
Oral Bioavail. 50 (inhala: 10) %
Molecular weight 239 daltons
Protein Binding 10 %
VD 2,2 l/Kg
pKa 10,12 -
Tmax 0,2 - 0,4 hours
T1/2 2,7 - 5 hours

Total visits


Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at

e-lactancia is a resource recommended by IHAN of Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM